arrow
Back
D

David Morris

johnson & johnson

12H-index
83Paper Count
1.2KCitation Count
Published Papers 24
Publication Date
PATIENT PREFERENCES, TREATMENT RECEIVED, AND QUALITY OF LIFE IN THE CISTO STUDY COMPARING RADICAL CYSTECTOMY OR BLADDER-SPARING THERAPY FOR RECURRENT HIGH-GRADE NMIBC
err2026-05-01
err0
PREAI
errGore, John L.; Wolff, Erika M.; Nash, Michael G.; Comstock, Bryan A.; Lee, Jenney R.; Basu, Anirban; Roscoe, Lori A.; Ikema, Christiana; Gilbert, Scott M.; Wright, Jonathan L.; Kates, Max R.; Pohar, Kamal S.; Guzzo, Thomas J.; Bivalacqua, Trinity J.; Nepple, Kenneth G.; Montgomery, Jeffrey S.; Scarpato, Kristen R.; Woldu, Solomon L.; Mossanen, Matthew; Master, Viraj A.; Chen, David Y. T.; Daneshmand, Siamak; O'Neil, Brock B.; Tyson, Mark D.; Westerman, Mary E.; Kamat, Ashish M.; Mansour, Ahmed M.; Chamie, Karim; Riggs, Stephen B.; Kukreja, Janet B.; Modi, Parth K.; Peyton, Charles C.; Nix, Jeffrey W.; Garg, Tullika; Dickstein, Rian; Gadzinski, Adam J.; Sankin, Alex; Shore, Neal D.; Lane, Brian R.; Bassett, Jeffrey C.; Patel, Sanjay; Morris, David S.; Lee, Eugene K.; Macleod, Liam C.; Ritch, Chad R.; Kim, Sung Min; Follmer, Kristin M.; Smith, Angela B.
errShare
errSave
Side effect management and procedural best practices with indwelling intravesical drug-releasing systems in the treatment of bladder cancer: recommendations from expert panels
err2026-01-01
err0
PREAI
errPradere, Benjamin; Schuit, Maarten; Guerrero-Ramos, Felix; Shariat, Shahrokh F.; Kitamura, Hiroshi; Jacob, Joseph M.; Bao, Yige; Heesakkers, John; Peters, Kenneth M.; Cahn, David J.; De Troyer, Bart; Herrera Imbroda, Bernardo; Morris, David S.; Pieczonka, Christopher M.; Wei, Qiang; Bhanvadia, Sumeet; Somer, Robert; Jessner, Wolfgang; Triantos, Spyros; Sanchez de Llano, Cristina; Maffeo, John C.; Sweiti, Hussein; Psutka, Sarah P.
errShare
errSave
To Sculpt an Ear: A Practical Exercise for Teaching the Surgeon to See Form
err2025-10-01
err0
PREAI
errBlackman, Camille; Mathis, Sydney; Arias, Eduardo; Seelaus, Rosemary; Morris, David
errShare
errSave
Using patient-reported outcomes from the PROCLAIM trial to assess the impact of universal germline genetic testing for prostate cancer patients
err2025-09-22
err0
errOAAI
errNeal D. Shore; Christopher M. Pieczonka; Sean Heron; Mukaram Gazi; David J. Cahn; Laurence H. Belkoff; Aaron D. Berger; Brian Mazzarella; Joseph Veys; David Morris; Richard Bevan-Thomas; Alexander Engelman; Paul Dato; David R. Wise; Mary Kay Hardwick; Kerry W. Aradhya; Brandie Heald; Robert L. Nussbaum; Kathryn E. Hatchell; Brianna Bucknor; Edward D. Esplin; Sarah M. Nielsen
errShare
errSave
Clinician-Reported Management Recommendations in Response to Universal Germline Genetic Testing in Patients With Prostate Cancer
err2024-12-01
err3
PREAI
errShore, Neal; Pieczonka, Christopher; Heron, Sean; Gazi, Mukaram; Cahn, David; Belkoff, Laurence H.; Berger, Aaron; Mazzarella, Brian; Veys, Joseph; Idom, Charles; Morris, David; Jayram, Gautam; Engelman, Alexander; Dato, Paul; Bevan-Thomas, Richard; Wise, David R.; Hardwick, Mary Kay; Rojahn, Susan; Layman, Paige; Heald, Brandie; Ellsworth, Rachel E.; Hatchell, Kathryn E.; Nussbaum, Robert L.; Nielsen, Sarah M.; Esplin, Edward D.
errShare
errSave
Development and Optimization of a Subtraction-Normalized Immunocyte Profiling Signature for Prostate Cancer Active Surveillance Risk Stratification
err2024-03-01
err0
errOAAI
errVan Neste, Leander; Henao, Ricardo; Wojno, Kirk J.; Signes, Jorge; Dehart, Jessica; Busta, Angela; Marriott, Elyse; Willing, Marian; Argentini, Andrea; Hurley, Patrick M.; Korman, Howard; Hafron, Jason; Putzi, Mathew; Pieczonka, Chris M.; Karsh, Lawrence I.; Morris, David S.; Kassis, Amin I.; Kantoff, Philip W.
errShare
errSave
Results from SunRISe-1 in patients (Pts) with bacillus CalmetteeGuerin (BCG)-unresponsive high-risk non emuscle-invasive bladder cancer (HR NMIBC) receiving TAR200 monotherapy
err2023-10-01
err9
errOAAI
errNecchi, A.; Jacob, J. M.; Daneshmand, S.; Simone, G.; Xylinas, E.; Morris, D.; Spiegelhalder, P.; Zainfeld, D.; Kang, T. W.; Matulay, J. T.; Belkoff, L.; Decaestecker, K.; Arentsen, H.; Hampras, S.; Cutie, C.; Sweiti, H.; Stromberg, K.; Martin, J.; Shukla, A.; van der Heijden, M. S.
errShare
errSave
Efficacy of National Comprehensive Cancer Network Guidelines in Identifying Pathogenic Germline Variants Among Unselected Patients with Prostate Cancer: The PROCLAIM Trial
err2023-10-01
err8
errOAAI
errShore, Neal; Gazi, Mukaram; Pieczonka, Christopher; Heron, Sean; Modh, Rishi; Cahn, David; Belkoff, Laurence H.; Berger, Aaron; Mazzarella, Brian; Veys, Joseph; Idom, Charles; Morris, David; Jayram, Gautam; Engelman, Alexander; Bukkapatnam, Raviender; Dato, Paul; Bevan-Thomas, Richard; Cornell, Robert; Wise, David R.; Hardwick, Mary Kay; Hernandez, Ryan D.; Rojahn, Susan; Layman, Paige; Hatchell, Kathryn E.; Heald, Brandie; Nussbaum, Robert L.; Nielsen, Sarah M.; Esplin, Edward D.
errShare
errSave
SunRISe-3: TAR-200 plus cetrelimab (CET) or TAR-200 versus intravesical bacillus Calmette-Guerin (BCG) in patients (pts) with BCG-naive high-risk non-muscle-invasive bladder cancer (HR NMIBC)
err2023-10-01
err4
errOAAI
errNecchi, A.; Catto, J. W. F.; Powles, T. B.; Guerrero-Ramos, F.; Simone, G.; Shore, N. D.; Salinas, J.; Merseburger, A. S.; Roumiguie, M.; Kitamura, H.; Morris, D.; Wei, Q.; Korkes, F.; Hasan, M.; Jin, S.; Maffeo, J.; Hammond, C.; Sweiti, H.; Somer, R.; Chang, S. S.
errShare
errSave
Safety, Tolerability, and Preliminary Efficacy of TAR-200 in Patients With Muscle-invasive Bladder Cancer Who Refused or Were Unfit for Curative-intent Therapy: A Phase 1 Study
err2023-05-01
err13
errOAAI
errTyson, Mark D.; Morris, David; Palou, Juan; Rodriguez, Oscar; Mir, Maria Carmen; Dickstein, Rian J.; Guerrero-Ramos, Felix; Scarpato, Kristen R.; Hafron, Jason M.; Messing, Edward M.; Cutie, Christopher J.; Maffeo, John C.; Raybold, Bradley; Chau, Albert; Stromberg, Katharine A.; Keegan, Kirk A.
errShare
errSave
Safety, Tolerability, and Preliminary Efficacy of TAR-200 inPatients With Muscle-invasive Bladder Cancer Who Refused orWere Unfit for Curative-intent Therapy: A Phase 1 Study Reply
err2023-05-01
err0
PREAI
errTyson, Mark D.; Morris, David; Palou, Juan; Rodriguez, Oscar; Mir, Maria Carmen; Dickstein, Rian J.; Guerrero-Ramos, Felix; Scarpato, Kristen R.; Hafron, Jason M.; Messing, Edward M.; Cutie, Christopher J.; Maffeo, John C.; Raybold, Bradley; Chau, Albert; Stromberg, Katharine A.; Keegan, Kirk A.
errShare
errSave
Rucaparib or Physician's Choice in Metastatic Prostate Cancer
err2023-02-23
err161
errOAAI
errFizazi, K.; Piulats, J. M.; Reaume, M. N.; Ostler, P.; McDermott, R.; Gingerich, J. R.; Pintus, E.; Sridhar, S. S.; Bambury, R. M.; Emmenegger, U.; Lindberg, H.; Morris, D.; Nole, F.; Staffurth, J.; Redfern, C.; Saez, M. I.; Abida, W.; Daugaard, G.; Heidenreich, A.; Krieger, L.; Sautois, B.; Loehr, A.; Despain, D.; Heyes, C. A.; Watkins, S. P.; Chowdhury, S.; Ryan, C. J.; Bryce, A. H.
errShare
errSave
Phase Ib/II Study of Enzalutamide with Samotolisib (LY3023414) or Placebo in Patients with Metastatic Castration-Resistant Prostate Cancer
err2022-04-01
err24
errOAAI
errSweeney, Christopher J.; Percent, Ivor J.; Babu, Sunil; Cultrera, Jennifer L.; Mehlhaff, Bryan A.; Goodman, Oscar B.; Morris, David S.; Schnadig, Ian D.; Albany, Costantine; Shore, Neal D.; Sieber, Paul R.; Guba, Susan C.; Zhang, Wei; Wacheck, Volker; Donoho, Gregory P.; Szpurka, Anna M.; Callies, Sophie; Lin, Boris Kin; Bendell, Johanna C.
errShare
errSave
Genetic testing in prostate cancer management: Considerations informing primary care
err2022-02-24
err26
errOAAI
errGiri, Veda N.; Morgan, Todd M.; Morris, David S.; Berchuck, Jacob E.; Hyatt, Colette; Taplin, Mary-Ellen
errShare
errSave
Universal germline testing of prostate cancer patients: Are genetic testing guidelines an aid or an impediment to precision therapy?
err2021-09-01
err0
errOAAI
errHardwick, M. K.; Esplin, E.; Mazzerelli, B.; Morris, D.; Heron, S.; Veys, J.; Engelman, A.; Dato, P.; Bevan-Thomas, R.; Wise, D.; Cornell, R.; Berger, A.; Nielsen, S.; Hatchell, K.; Nussbaum, R.; Gazi, M.; Pieczonka, C. M.; Belkoff, L.; Cahn, D. J.; Shore, N. D.
errShare
errSave
Double-blinded manuscript review: Avoiding peer review bias
err2021-04-26
err4
PREAI
errSantos, Ariel; Morris, David S.; Rattan, Rishi; Zakrison, Tanya
errShare
errSave
TREC Screening for WHIM Syndrome (Jan, 10.1007/s10875-020-00921-4, 2021)
err2021-01-28
err0
errOAAI
errOman Evans, Martin, II; Petersen, Maureen M.; Khojah, Amer; Jyonouchi, Soma C.; Edwardson, George S.; Khan, Yasmin West; Connelly, James Albert; Morris, David; Majumdar, Shamik; McDermott, David H.; Walter, Jolan E.; Murphy, Philip M.
errShare
errSave
TREC Screening for WHIM Syndrome
err2021-01-07
err5
errOAAI
errEvans, Martin Oman, II; Petersen, Maureen M.; Khojah, Amer; Jyonouchi, Soma C.; Edwardson, George S.; Khan, Yasmin West; Connelly, James Albert; Morris, David; Majumdar, Shamik; McDermott, David H.; Walter, Jolan E.; Murphy, Philip M.
errShare
errSave
Treatment Patterns, Patient Characteristics, and Preliminary Safety in the Radium-223 (Ra-223) REASSURE Observational Study
err2017-10-01
err0
errOAAI
errZimberg, S. H.; Richardson, T.; Sylvester, J. E.; Given, R.; Kipper, M.; Mantz, C.; Morris, D.; Perlmutter, M.; Song, D.; Fernandez, E.; Brookland, R. K.; Tchekmedyian, N.; Hafron, J.; Hartford, A. C.; Peddada, A. V.; Vacirca, J.; De Sanctis, Y.; Muenz-Wollny, R.; Conti, P.
errShare
errSave
Practice Based Collaboration to Improve the Use of Immediate Intravesical Therapy after Resection of Nonmuscle Invasive Bladder Cancer
err2013-12-01
err34
PREAI
errBarocas, Daniel A.; Liu, Alice; Burks, Frank N.; Suh, Ronald S.; Schuster, Timothy G.; Bradford, Timothy; Moylan, Don A.; Knapp, Peter M.; Murtagh, Daniel S.; Morris, David; Dunn, Rodney L.; Montie, James E.; Miller, David C.
errShare
errSave